Effects of NOL8 on cell proliferation, migration and invasion of oral squamous cell carcinoma

doi:10.19401/j.cnki.1007-3639.2023.01.005

Abstract

Abstract:

Background and purpose: Oral squamous cell carcinoma (OSCC) is the most common subtype of head and neck squamous cell carcinoma (HNSCC), and its pathogenesis is unclear. Nucleolar protein 8 (NOL8), as one of the RNA-binding protein (RBP), plays a key role in the occurrence and development of many kinds of tumors, however its role in OSCC is not clear. This study aimed to investigate the expression level of NOL8 in OSCC and its effects on the proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) of OSCC. Methods: The expression of NOL8 in HNSCC was analyzed online by gene expression profiling interactive analysis 2 (GEPIA2), tumor immune estimation resource (TIMER), the University of Alabama at Birmingham cancer data analysis portal (UALCAN) and the encyclopedia of RNA interactomes (ENCORI). The mRNA expression level of NOL8 in OSCC cells was detected by real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR). siRNA interference technique was used to knock down the expression of NOL8 in CAL-27 cells to form NOL8 knockdown group (si-NOL8-1, si-NOL8-2) and negative control group. CAL-27 and HN6 cells were overexpressed with NOL8 by lentivirus transfection technique to form NOL8 overexpression group and negative control group. Cell counting kit-8 (CCK-8) assay, scratch healing assay and transwell assay were used to detect the effect of NOL8 expression on the proliferation, migration and invasion of OSCC cells. Western blot assay was used to detect the effect of NOL8 on the expression of EMT-related genes including E-cadherin, vimentin and N-cadherin. The effect of NOL8 on the proliferation of OSCC cells in vivo was examed by xenograft formation assays. Results: The online analysis of GEPIA2, TIMER, UALCAN and ENCORI showed that the expression of NOL8 was higher in HNSCC than in normal tissues, and the expression of NOL8 in OSCC was significantly higher than in normal control cells. The relative expression of NOL8 in CAL-27 cells transfected with si-NOL8-1 and si-NOL8-2 was significantly lower compared with the negative control group. The results of CCK-8 assay, scratch healing assay and transwell assay showed that the proliferative ability, cell migration rate and invasion number of CAL-27 cells were significantly decreased after knockdown of NOL8 expression. The relative expression of NOL8 in CAL-27 and HN6 cells transfected with NOL8 was significantly higher compared with the control group. The proliferative ability, cell migration rate and invasion number of CAL-27 and HN6 cells in the overexpression NOL8 group were significantly higher compared with the negative control group. The results of Western blot showed that in CAL-27 cells, the expression of E-cadherin increased and the expressions of N-cadherin and vimentin decreased after NOL8 knockdown, while in CAL-27 and HN6 cells, the expression of E-cadherin decreased and the expressions of N-cadherin and vimentin increased after NOL8 overexpression. The xenograft formation assays showed that the weight of tumor was significantly higher in NOL8 overexpression group than in NOL8 control group. Conclusion: NOL8 is highly expressed in OSCC and can promote the proliferation, migration and invasion of OSCC, which may be related to the process of EMT.

Key words: Oral squamous cell carcinoma, Nucleolar protein 8, Proliferation, Migration, Invasion

CLC Number:

R739.85

WANG Xiaoxiao, CHEN Xi, LI Minmin, SONG Ning, SUN Dongyuan, JIANG Yingying. Effects of NOL8 on cell proliferation, migration and invasion of oral squamous cell carcinoma[J]. China Oncology, 2023, 33(1): 45-53.

Figures/Tables 7

Fig. 1

Fig. 2

Fig. 3

Fig. 4

Fig. 5

Fig. 6

Fig. 7

References 20

[1]	CHEN W Q, ZHENG R S, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132. doi: 10.3322/caac.21338
[2]	AUGUSTE A, JOACHIM C, DELOUMEAUX J, et al. Head and neck cancer risk factors in the French West Indies[J]. BMC Cancer, 2021, 21(1): 1071. doi: 10.1186/s12885-021-08787-4 pmid: 34592954
[3]	OOSTING S F, HADDAD R I. Best practice in systemic therapy for head and neck squamous cell carcinoma[J]. Front Oncol, 2019, 9: 815. doi: 10.3389/fonc.2019.00815 pmid: 31508372
[4]	SPECENIER P, VERMORKEN J B. Optimizing treatments for recurrent or metastatic head and neck squamous cell carcinoma[J]. Expert Rev Anticancer Ther, 2018, 18(9): 901-915. doi: 10.1080/14737140.2018.1493925
[5]	DU E, MAZUL A L, FARQUHAR D, et al. Long-term survival in head and neck cancer: impact of site, stage, smoking, and human papillomavirus status[J]. Laryngoscope, 2019, 129(11): 2506-2513. doi: 10.1002/lary.27807
[6]	GU S, HOU P J, LIU K, et al. NOL8, the binding protein for beta-catenin, promoted the growth and migration of prostate cancer cells[J]. Chem Biol Interact, 2018, 294: 40-47. doi: 10.1016/j.cbi.2018.08.019
[7]	MO J S, CHAE S C. microRNA 452 regulates ASB8, NOL8, and CDR2 expression in colorectal cancer cells[J]. Genes Genomics, 2021, 43(1): 33-41. doi: 10.1007/s13258-020-01016-5
[8]	JINAWATH N, FURUKAWA Y, NAKAMURA Y. Identification of NOL8, a nucleolar protein containing an RNA recognition motif (RRM), which was overexpressed in diffuse-type gastric cancer[J]. Cancer Sci, 2004, 95(5): 430-435. doi: 10.1111/j.1349-7006.2004.tb03227.x
[9]	LU Y J, YAN Y C, LI B W, et al. A novel prognostic model for oral squamous cell carcinoma: the functions and prognostic values of RNA-binding proteins[J]. Front Oncol, 2021, 11: 592614. doi: 10.3389/fonc.2021.592614
[10]	SEKIGUCHI T, HAYANO T, YANAGIDA M, et al. NOP132 is required for proper nucleolus localization of DEAD-box RNA helicase DDX47[J]. Nucleic Acids Res, 2006, 34(16): 4593-4608. pmid: 16963496
[11]	O’LEARY D A, SHARIF O, ANDERSON P, et al. Identification of small molecule and genetic modulators of AON-induced dystrophin exon skipping by high-throughput screening[J]. PLoS One, 2009, 4(12): e8348. doi: 10.1371/journal.pone.0008348
[12]	TANG Z F, LI C W, KANG B X, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses[J]. Nucleic Acids Res, 2017, 45(W1): W98-W102. doi: 10.1093/nar/gkx247
[13]	LI T W, FU J X, ZENG Z X, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells[J]. Nucleic Acids Res, 2020, 48(W1): W509-W514. doi: 10.1093/nar/gkaa407
[14]	CHANDRASHEKAR D S, BASHEL B, BALASUBRAMANYA S A H, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses[J]. Neoplasia, 2017, 19(8): 649-658. doi: S1476-5586(17)30179-3 pmid: 28732212
[15]	LI J H, LIU S, ZHOU H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data[J]. Nucleic Acids Res, 2014, 42(Database issue): D92-D97. doi: 10.1093/nar/gkt1248
[16]	HEDBERG M L, GOH G, CHIOSEA S I, et al. Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma[J]. J Clin Invest, 2016, 126(4): 1606. doi: 10.1172/JCI86862 pmid: 27035818
[17]	MASUDA K, KUWANO Y. Diverse roles of RNA-binding proteins in cancer traits and their implications in gastrointestinal cancers[J]. Wiley Interdiscip Rev RNA, 2019, 10(3): e1520.
[18]	LIU J W, LI H, SHEN S X, et al. Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer[J]. J Cancer, 2018, 9(10): 1754-1764. doi: 10.7150/jca.24569 pmid: 29805701
[19]	MITTAL V. Epithelial mesenchymal transition in tumor metastasis[J]. Annu Rev Pathol, 2018, 13: 395-412. doi: 10.1146/annurev-pathol-020117-043854 pmid: 29414248
[20]	周锦翰, 刘传霞, 葛巍立, 等. 上皮-间充质转化在口腔鳞状细胞癌发生、发展中作用的研究进展[J]. 浙江医学, 2021, 43(20): 2258-2262.
	ZHOU J H, LIU C X, GE W L, et al. The role of epithelial mesenchymal transformation in the genesis and development of oral squamous cell carcinoma[J]. Zhejiang Med J, 2021, 43(20): 2258-2262.